These studies suggest that overcoming IL-6-mediated cell resistance by SANT-7 potentiates the effect of glucocorticoides and bisphosphonates on MM cell growth and survival, providing a rationale for therapies using IL-6 antagonists in MM. This evidence concerns the gene IL6 and Miyoshi myopathy.